ESLA · Estrella Immunopharma, Inc. · Fails to Deliver
$0.47
-0.01 (-1.47%)
At close · Oct 2
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result, management has determined that there is a substantial doubt about its ability to continue as a going concern. If the Company is unable to obtain adequate financing or generate significant revenue, it may be required to curtail or cease its operations.”View the 10-Q filed Aug 13, 2026
Market Cap
$20.92M
Shares
43.50M
Volume · Oct 2
14.49K
Avg daily vol (3M)
37.45K
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-09-14 | 60 | $0.69 | $41 |
| 2026-09-11 | 3,649 | $0.67 | $2,445 |
| 2026-09-10 | 5,597 | $0.64 | $3,582 |
| 2026-09-08 | 662 | $0.65 | $430 |
| 2026-09-02 | 2,447 | $0.69 | $1,688 |
| 2026-09-01 | 3,061 | $0.73 | $2,235 |
| 2026-08-31 | 331 | $0.69 | $228 |
| 2026-08-28 | 5,134 | $0.72 | $3,696 |
| 2026-08-27 | 268 | $0.73 | $196 |
| 2026-08-26 | 1,061 | $0.77 | $817 |
| 2026-08-24 | 121 | $0.74 | $90 |
| 2026-08-17 | 640 | $0.72 | $461 |
| 2026-08-14 | 747 | $0.72 | $538 |
| 2026-08-06 | 14,323 | $0.75 | $10,742 |
| 2026-08-04 | 4 | $0.70 | $3 |
| 2026-07-28 | 3,151 | $0.77 | $2,426 |
| 2026-07-24 | 459 | $0.76 | $349 |
| 2026-07-22 | 334 | $0.80 | $267 |
| 2026-07-21 | 1,868 | $0.82 | $1,532 |
| 2026-07-08 | 553 | $0.93 | $514 |
| 2026-07-07 | 558 | $1.02 | $569 |
| 2026-07-06 | 105 | $0.98 | $103 |
Showing 1–22 of 22 settlements